Endovascular Treatment of Veno-Occlusive Behcet's Disease

Basit Öğe Kaydı
dc.contributor.authorTekbas, Guven
dc.contributor.authorOguzkurt, Levent
dc.contributor.authorGur, Serkan
dc.contributor.authorOnder, Hakan
dc.contributor.authorAndic, Cagatay
dc.date.accessioned2024-04-24T15:59:58Z
dc.date.available2024-04-24T15:59:58Z
dc.date.issued2012
dc.departmentDicle Üniversitesien_US
dc.description.abstractTo retrospectively evaluate the outcome of endovascular treatments for patients with chronic veno-occlusive disease in different vascular beds secondary to Behcet's disease (BD). There are few case reports on the subject, and this is the largest study to date. From January 2001 through October 2009, chronic venous occlusions were treated in 10 patients (all male [age range 18-76 years]) with BD using percutaneous transluminal angioplasty and/or stent placement. All patients were symptomatic and had chronic iliofemoral deep venous thrombosis (DVT; n = 5), central venous occlusion (n = 3), or Budd-Chiari syndrome (BCS; n = 2). All patients met criteria of the International Study Group on Behcet's Disease. Two of five patients with DVT had unsuccessful recanalization attempts. Three patients had successful recanalization with stent placement. All three veins were occluded within 1 month with unsuccessful reinterventions. Three patients with chronic central venous occlusion had successful recanalization with percutaneous transluminal angioplasty (n = 1) and stent placement (n = 2). Two patients had reocclusion with successful reintervention. Two BCS patients had successful treatment with stent placements. Overall technical success was 69%, and no procedural complications were encountered. None of the patients with chronic DVT had patent veins; however, all patients with central venous occlusion or BCS had patent veins on color Doppler ultrasonography at follow-up ranging from 3 to 48 months after intervention. Endovenous treatment for chronic iliofemoral DVT due to BD had a poor outcome. However, long-term outcome after endovenous treatment for upper-extremity central venous occlusion and BCS syndrome was good.en_US
dc.identifier.doi10.1007/s00270-011-0322-8
dc.identifier.endpage831en_US
dc.identifier.issn0174-1551
dc.identifier.issn1432-086X
dc.identifier.issue4en_US
dc.identifier.pmid22167305
dc.identifier.scopus2-s2.0-84866618302
dc.identifier.scopusqualityQ1
dc.identifier.startpage826en_US
dc.identifier.urihttps://doi.org/10.1007/s00270-011-0322-8
dc.identifier.urihttps://hdl.handle.net/11468/14327
dc.identifier.volume35en_US
dc.identifier.wosWOS:000306425200013
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoenen_US
dc.publisherSpringeren_US
dc.relation.ispartofCardiovascular and Interventional Radiology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectVenous Interventionen_US
dc.subjectAngioplasty/Angiogramen_US
dc.subjectEndovascular Treatmenten_US
dc.titleEndovascular Treatment of Veno-Occlusive Behcet's Diseaseen_US
dc.titleEndovascular Treatment of Veno-Occlusive Behcet's Disease
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu